265 related articles for article (PubMed ID: 16625082)
1. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
Radfar A; Stefanato CM; Ghosn S; Bhawan J
Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
[TBL] [Abstract][Full Text] [Related]
2. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
Lazova R; Tantcheva-Poor I; Sigal AC
J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
[TBL] [Abstract][Full Text] [Related]
3. KBA.62: a useful marker for primary and metastatic melanomas.
Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
[TBL] [Abstract][Full Text] [Related]
4. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
[TBL] [Abstract][Full Text] [Related]
5. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
Kanik AB; Yaar M; Bhawan J
J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
[TBL] [Abstract][Full Text] [Related]
6. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
8. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
9. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
[TBL] [Abstract][Full Text] [Related]
11. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
13. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
14. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
[TBL] [Abstract][Full Text] [Related]
15. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
17. Sox10: a pan-schwannian and melanocytic marker.
Nonaka D; Chiriboga L; Rubin BP
Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
[TBL] [Abstract][Full Text] [Related]
18. An unusual case of desmoplastic melanoma containing an osteoclast-like giant cell-rich nodule.
Houang M; Castillo C; La Marca S; Combemale P; Wang Q; Paindavoine S; Pissaloux D; de la Fouchardiere A
Am J Dermatopathol; 2015 Apr; 37(4):299-304. PubMed ID: 24999544
[TBL] [Abstract][Full Text] [Related]
19. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
McCluggage WG; Bissonnette JP; Young RH
Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
[TBL] [Abstract][Full Text] [Related]
20. Low-affinity nerve growth factor receptor (P75 NGFR) as a marker of perineural invasion in malignant melanomas.
Chan MM; Tahan SR
J Cutan Pathol; 2010 Mar; 37(3):336-43. PubMed ID: 19615036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
